Juan Carlos Vella Ramírez, Enrique Rodríguez García, Carlos Romero Román, Beatriz Candás Estébanez, María José Castro Castro, Teresa Arrobas Velilla, Pilar Calmarza Calmarza, Margarita Esteban Salán, Miguel Pocoví Mieras, José Puzo Foncillas
{"title":"脂质和脂蛋白测量标准化的建议。建议(2018年)","authors":"Juan Carlos Vella Ramírez, Enrique Rodríguez García, Carlos Romero Román, Beatriz Candás Estébanez, María José Castro Castro, Teresa Arrobas Velilla, Pilar Calmarza Calmarza, Margarita Esteban Salán, Miguel Pocoví Mieras, José Puzo Foncillas","doi":"10.1016/j.labcli.2018.08.002","DOIUrl":null,"url":null,"abstract":"<div><p>Some recommendations are presented for standardising the measurement of lipids and lipoproteins, as they are critical for clinical decisions making. Recommended methods validated against a reference or definitive method should be employed, as well as the use of control materials that comply with European Directives on <em>in vitro</em> diagnostics. Additionally, the chosen methods must comply with the objectives set forth by the National Cholesterol Education Program (NCEP) and by the Spanish Society of Laboratory Medicine (SEQC<sup>ML</sup>). Determination of HDL cholesterol using automatic homogenous methods is considered acceptable for normal clinical practice, and the Friedewald Formula is considered to be usable to estimate LDL cholesterol concentration when triglyceride concentrations are below 200<!--> <!-->mg/dL (2.3<!--> <!-->mmol/L). If this should not be the case, the use of non-HDL cholesterol is recommended. Routine quantification of apolipoproteins A1 and B, and lipoprotein (a) can be measured using immunonephelometric or immunoturbidimetric methods, with calibrators that are traceable to reference materials.</p></div>","PeriodicalId":101105,"journal":{"name":"Revista del Laboratorio Clínico","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.labcli.2018.08.002","citationCount":"2","resultStr":"{\"title\":\"Recomendaciones para la estandarización de la medida de lípidos y lipoproteínas. Recomendación (2018)\",\"authors\":\"Juan Carlos Vella Ramírez, Enrique Rodríguez García, Carlos Romero Román, Beatriz Candás Estébanez, María José Castro Castro, Teresa Arrobas Velilla, Pilar Calmarza Calmarza, Margarita Esteban Salán, Miguel Pocoví Mieras, José Puzo Foncillas\",\"doi\":\"10.1016/j.labcli.2018.08.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Some recommendations are presented for standardising the measurement of lipids and lipoproteins, as they are critical for clinical decisions making. Recommended methods validated against a reference or definitive method should be employed, as well as the use of control materials that comply with European Directives on <em>in vitro</em> diagnostics. Additionally, the chosen methods must comply with the objectives set forth by the National Cholesterol Education Program (NCEP) and by the Spanish Society of Laboratory Medicine (SEQC<sup>ML</sup>). Determination of HDL cholesterol using automatic homogenous methods is considered acceptable for normal clinical practice, and the Friedewald Formula is considered to be usable to estimate LDL cholesterol concentration when triglyceride concentrations are below 200<!--> <!-->mg/dL (2.3<!--> <!-->mmol/L). If this should not be the case, the use of non-HDL cholesterol is recommended. Routine quantification of apolipoproteins A1 and B, and lipoprotein (a) can be measured using immunonephelometric or immunoturbidimetric methods, with calibrators that are traceable to reference materials.</p></div>\",\"PeriodicalId\":101105,\"journal\":{\"name\":\"Revista del Laboratorio Clínico\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.labcli.2018.08.002\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista del Laboratorio Clínico\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1888400818300758\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista del Laboratorio Clínico","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1888400818300758","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Recomendaciones para la estandarización de la medida de lípidos y lipoproteínas. Recomendación (2018)
Some recommendations are presented for standardising the measurement of lipids and lipoproteins, as they are critical for clinical decisions making. Recommended methods validated against a reference or definitive method should be employed, as well as the use of control materials that comply with European Directives on in vitro diagnostics. Additionally, the chosen methods must comply with the objectives set forth by the National Cholesterol Education Program (NCEP) and by the Spanish Society of Laboratory Medicine (SEQCML). Determination of HDL cholesterol using automatic homogenous methods is considered acceptable for normal clinical practice, and the Friedewald Formula is considered to be usable to estimate LDL cholesterol concentration when triglyceride concentrations are below 200 mg/dL (2.3 mmol/L). If this should not be the case, the use of non-HDL cholesterol is recommended. Routine quantification of apolipoproteins A1 and B, and lipoprotein (a) can be measured using immunonephelometric or immunoturbidimetric methods, with calibrators that are traceable to reference materials.